- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/18 - Erythrocytes
Patent holdings for IPC class A61K 35/18
Total number of patents in this class: 427
10-year publication summary
|
29
|
25
|
43
|
54
|
43
|
43
|
39
|
22
|
27
|
20
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Rubius Therapeutics, Inc. | 65 |
34 |
| Erytech Pharma | 69 |
23 |
| Hemanext Inc. | 90 |
17 |
| RegenLab USA LLC | 77 |
16 |
| The Regents of the University of California | 20015 |
13 |
| Biomet Manufacturing, LLC | 1016 |
12 |
| Biomet, Inc. | 127 |
7 |
| Boston Medical Center Corporation | 112 |
7 |
| ZB Manufacturing, LLC | 114 |
7 |
| Cerus Corporation | 93 |
6 |
| Trustees of Boston University | 976 |
6 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3174 |
6 |
| Quince Therapeutics S.p.A. | 19 |
6 |
| The General Hospital Corporation | 4751 |
5 |
| Terumo Kabushiki Kaisha | 5566 |
5 |
| ViaCell, LLC | 6 |
5 |
| Whitehead Institute for Biomedical Research | 320 |
5 |
| Sangamo Therapeutics, Inc. | 418 |
5 |
| Beam Therapeutics Inc. | 239 |
5 |
| Westlake Therapeutics (Hangzhou) Co. Limited | 18 |
5 |
| Other owners | 232 |